By Adam Boros, PhD – Drug Discovery News –
Genetically modified stem cells show promise in a targeted approach to taming inflammation in autoimmune diseases. Researchers developed an immunotherapy using chimeric antigen receptors and mesenchymal stromal cells, paving the way for more precise immunomodulation.
